Cite
Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship.
MLA
Salem, Ahmed M., et al. “Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship.” Journal of Clinical Pharmacology, vol. 64, no. 1, Jan. 2024, pp. 30–44. EBSCOhost, https://doi.org/10.1002/jcph.2333.
APA
Salem, A. M., Smith, T., Wilkes, J., Bailly, D. K., Heyrend, C., Profsky, M., Yellepeddi, V. K., & Gopalakrishnan, M. (2024). Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship. Journal of Clinical Pharmacology, 64(1), 30–44. https://doi.org/10.1002/jcph.2333
Chicago
Salem, Ahmed M., Trey Smith, Jacob Wilkes, David K. Bailly, Caroline Heyrend, Michael Profsky, Venkata K. Yellepeddi, and Mathangi Gopalakrishnan. 2024. “Pharmacokinetic Modeling Using Real‐World Data to Optimize Unfractionated Heparin Dosing in Pediatric Patients on Extracorporeal Membrane Oxygenation and Evaluate Target Achievement–Clinical Outcomes Relationship.” Journal of Clinical Pharmacology 64 (1): 30–44. doi:10.1002/jcph.2333.